ENGITIX

• 72110 - Research and experimental development on biotechnology

Engitix was created in 2016 to commercialise cutting-edge ECM research at the Institute for Liver and Digestive Health, Division of Medicine, University College London (UCL) and is now a growing biotechnology company with a discovery stage therapeutic portfolio and over 50 employees... Engitix has a 13,000 square feet facility of purpose-designed office and laboratory space that houses the latest state-of-the-art research instruments and tools. Located at the Westworks building in the prestigious new life science cluster at White City Place, London, UK, we provide a stimulating and innovative research environment with excellent networking opportunities... Our patient-centric ECM platform is underpinned by an extensive bioarchive, one of the world's largest ECM databases, and best-in-class, human in vitro 3-D cell culture bioassays. Together, these unique capabilities transform our ability to identify new targets and biomarkers, investigate novel mechanisms of action, and more..

Also known as: ENGITIX LIMITED, Engitix Ltd

Registration numbers: 10290441 (CH)

Primary location: London United Kingdom